Predictive value of the systemic immune-inflammation index for cancer-specific survival of osteosarcoma in children

BACKGROUND: Osteosarcoma (OS) is the primary malignant bone tumor that most commonly affects children and adolescents. Recent years effective chemotherapy have improved the 5-year survival in osteosarcoma patients to up to 60%-70%. Still, there is a lack of novel therapeutic strategies to enhance fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouyang, Haiping, Wang, Zhongliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363629/
https://www.ncbi.nlm.nih.gov/pubmed/35968442
http://dx.doi.org/10.3389/fpubh.2022.879523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363629/
https://www.ncbi.nlm.nih.gov/pubmed/35968442
http://dx.doi.org/10.3389/fpubh.2022.879523

Ejemplares similares